BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24023357)

  • 1. Anal carcinoma: surgery does not influence prognosis when performed prior to concurrent radiochemotherapy.
    Badakhshi H; Budach V; Wust P; Graf R
    Anticancer Res; 2013 Sep; 33(9):4111-5. PubMed ID: 24023357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
    Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
    Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.
    Graf R; Wust P; Hildebrandt B; Gögler H; Ullrich R; Herrmann R; Riess H; Felix R
    Oncology; 2003; 65(1):14-22. PubMed ID: 12837978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma.
    Hatfield P; Cooper R; Sebag-Montefiore D
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):419-24. PubMed ID: 17919842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
    Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
    Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
    Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
    Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
    Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of the anal canal and local control.
    Valentini V; Mantello G; Luzi S; Macchia G; Manfrida S; Smaniotto D
    Rays; 1998; 23(3):586-94. PubMed ID: 9932478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer of the anal canal].
    Ruíz Molina JM; Gómez Aceytuno R; Gallardo Rincón D; Herrera R; Mondragón Sánchez RJ; Oñate Ocaña LF; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1997; 62(3):184-8. PubMed ID: 9480525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.